A versatile ultrafine and super-absorptive H(+)-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection.
A versatile ultrafine and super-absorptive H(+)-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection.
复制标题
一种多功能超细、高吸收性H()改性蒙脱石:用于代谢综合征干预和胃粘膜保护的应用。
DOI:
10.1039/d0bm00474j
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Tang Guping
中科院分区:
文献类型:
--
作者:
Wang Qiwen;Shen Jie;Mo Enqi;Zhang Haotian;Wang Jianwei;Hu Xiurong;Zhou Jun;Bai Hongzhen;Tang Guping
Metabolic syndrome (MetS) includes central obesity, hypertension, insulin resistance, and dyslipidemia and is closely related to nonalcoholic fatty liver disease, atherosclerotic cardiovascular disease (CVD) and type 2 diabetes mellitus, involving multiple causative factors. Current drug therapies for intervention and amelioration of MetS are essential in clinical treatment of metabolic disease. In this report, we proposed an H+-modified montmorillonite (H-MMT) using an acid modification method with ultrafine structure and super absorption ability as a potential drug for MetS. Hamsters fed a high-fat diet were orally treated with H-MMT and simvastatin was applied as a control. H-MMT lowered lipids by decreasing intestinal absorption and promoting lipid excretion, subsequently preventing obesity, fatty liver, and hyperlipidemia. Moreover, H-MMT was significantly safer and better tolerated by the liver compared to simvastatin, which was hepatotoxic. In addition, we found that H-MMT had protective effects on gastric mucosal damage. Therefore, this versatile H-MMT provides a potential strategy to effectively improve MetS and provide gastric mucosal protection in clinical applications.